Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LYRAOTCMKTS:RSLSDNASDAQ:STRRNASDAQ:WOK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLYRALyra Therapeutics$0.09-4.4%$0.11$0.08▼$0.34$5.82M0.041.88 million shs1.85 million shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shsSTRRStar Equity$2.05+2.5%$2.17$1.72▼$5.35$6.58M0.8717,994 shs10,482 shsWOKWORK Medical Technology Group LTD Ordinary Shares$0.80+14.1%$0.50$0.36▼$8.45$11.66MN/A1.18 million shs651,740 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLYRALyra Therapeutics0.00%-14.13%-12.57%-55.02%-71.80%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%STRRStar Equity0.00%-17.01%-1.23%-8.00%-55.56%WOKWORK Medical Technology Group LTD Ordinary Shares0.00%+39.66%+65.09%-5.39%+69,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLYRALyra Therapeutics3.0096 of 5 stars3.23.00.00.04.11.71.3RSLSDReShape LifesciencesN/AN/AN/AN/AN/AN/AN/AN/ASTRRStar Equity3.1761 of 5 stars3.55.00.00.01.81.71.3WOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLYRALyra Therapeutics 2.33Hold$2.002,177.90% UpsideRSLSDReShape Lifesciences 0.00N/AN/AN/ASTRRStar Equity 3.00Buy$5.00143.90% UpsideWOKWORK Medical Technology Group LTD Ordinary Shares 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RSLSD, WOK, STRR, and LYRA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025STRRStar EquityMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $5.003/14/2025LYRALyra TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$2.00 ➝ $2.00(Data available from 5/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLYRALyra Therapeutics$1.19M4.91N/AN/A$1.56 per share0.06RSLSDReShape Lifesciences$610K0.00N/A0.08$341.84 per share0.00STRRStar Equity$57.17M0.12$0.34 per share6.11$14.63 per share0.14WOKWORK Medical Technology Group LTD Ordinary Shares$11.51M1.01N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLYRALyra Therapeutics-$62.68M-$1.21N/AN/AN/A-6,635.76%-125.07%-59.74%8/12/2025 (Estimated)RSLSDReShape Lifesciences-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/ASTRRStar Equity$25.13M-$3.43N/AN/AN/A-12.41%-8.72%-4.62%8/12/2025 (Estimated)WOKWORK Medical Technology Group LTD Ordinary SharesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest RSLSD, WOK, STRR, and LYRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025STRRStar Equity-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million5/6/2025Q1 2025LYRALyra Therapeutics-$0.15-$0.12+$0.03-$0.13$0.16 million$0.18 million3/20/2025Q4 2024STRRStar Equity-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 million3/13/2025Q4 2024LYRALyra Therapeutics-$0.12-$0.16-$0.04-$0.16$0.21 million$0.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLYRALyra TherapeuticsN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLYRALyra TherapeuticsN/A3.643.64RSLSDReShape Lifesciences0.051.171.07STRRStar Equity0.212.051.60WOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLYRALyra Therapeutics95.62%RSLSDReShape LifesciencesN/ASTRRStar Equity3.84%WOKWORK Medical Technology Group LTD Ordinary SharesN/AInsider OwnershipCompanyInsider OwnershipLYRALyra Therapeutics3.25%RSLSDReShape LifesciencesN/ASTRRStar Equity33.51%WOKWORK Medical Technology Group LTD Ordinary SharesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLYRALyra Therapeutics5066.27 million62.39 millionOptionableRSLSDReShape Lifesciences50354,000N/ANot OptionableSTRRStar Equity4603.21 million2.14 millionNot OptionableWOKWORK Medical Technology Group LTD Ordinary Shares22614.59 millionN/AN/ARSLSD, WOK, STRR, and LYRA HeadlinesRecent News About These CompaniesUnivest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)May 22, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Closing of Registered OfferingMay 22, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Pricing of Registered OfferingMay 21, 2025 | globenewswire.comWORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 11, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025March 5, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.February 28, 2025 | globenewswire.comWORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024February 14, 2025 | prnewswire.comWORK Medical Technology Group LTD's Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024November 27, 2024 | globenewswire.comWORK Medical Technology Group LTD Announces Partial Exercise of Underwriters' Over-Allotment OptionAugust 29, 2024 | globenewswire.comWORK Medical Technology Group LTD Announces Closing of Initial Public OfferingAugust 26, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesQualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumSuper Micro Computer Stock Clears New Path Higher on Saudi OrdersBy Gabriel Osorio-Mazilli | May 22, 2025View Super Micro Computer Stock Clears New Path Higher on Saudi OrdersUnitedHealth Insiders Double Down: Is UNH Stock a Value Play?By Jeffrey Neal Johnson | May 19, 2025View UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Why Energy Stocks Like Exxon and Hess Are Back in FocusBy Gabriel Osorio-Mazilli | May 4, 2025View Why Energy Stocks Like Exxon and Hess Are Back in FocusRSLSD, WOK, STRR, and LYRA Company DescriptionsLyra Therapeutics NASDAQ:LYRA$0.09 0.00 (-4.36%) Closing price 04:00 PM EasternExtended Trading$0.09 0.00 (-0.80%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.ReShape Lifesciences OTCMKTS:RSLSDReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.Star Equity NASDAQ:STRR$2.04 +0.04 (+2.00%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK$0.80 +0.10 (+14.14%) Closing price 04:00 PM EasternExtended Trading$0.77 -0.03 (-4.01%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft's Outlook Brightens as Analysts Boost Bullish Ratings Palantir Scores First $1 Billion Contract; Is It Priced In? Tesla: Why Analysts Think It Could Jump Another 47% Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook 3 Dividend Stocks to Get You Through Tariff Volatility Apple Sinks After New 25% Tariff Announcement—What's The Bottom? MarketBeat Week in Review – 05/19 - 05/23 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.